Stanton F McHardy

San Antonio, TX, United States of America

Stanton F McHardy

USPTO Granted Patents = 23 

Average Co-Inventor Count = 3.1

ph-index = 5

Forward Citations = 106(Granted Patents)


Location History:

  • Coventry, RI (US) (2002 - 2009)
  • Conventry, RI (US) (2012)
  • Helotes, TX (US) (2009 - 2019)
  • Waring, TX (US) (2022 - 2023)
  • San Antonio, TX (US) (2014 - 2024)
  • Galveston, TX (US) (2022 - 2024)

Company Filing History:


Years Active: 2002-2025

Loading Chart...
23 patents (USPTO):

Title: The Innovative Mind of Stanton F. McHardy: Enhancing Cognition and Treating Disorders through Patent Inventions

Introduction:

Stanton F. McHardy, a visionary inventor hailing from Coventry, Rhode Island (US), is renowned for his groundbreaking work in the realm of pharmaceutical inventions. With an impressive portfolio of 9 patents, McHardy's contributions have significantly advanced the fields of cognitive enhancement and the treatment of various disorders.

Latest Patents:

1. Bicyclic [3.1.0] heteroaryl amides as type 1 glycine transport inhibitors: McHardy's invention of substituted bicyclic [3.1.0] heteroaryl amides has paved the way for novel glycine transport inhibitors. These compounds demonstrate efficacy in enhancing cognition and treating symptoms of schizophrenia and other psychoses, offering hope to millions of individuals in need.

2. 2-azabicyclo[3.3.1]nonane derivatives: McHardy's creation of 2-azabicyclo[3.3.1]nonane derivatives represents a significant breakthrough in pharmaceuticals. These derivatives hold promise in treating a range of disorders mediated by opioid receptors, including irritable bowel syndrome, addiction, depression, anxiety, schizophrenia, and eating disorders.

Career Highlights:

Throughout his illustrious career, Stanton F. McHardy has made significant strides in the pharmaceutical industry. Notably, he has contributed his expertise to renowned companies such as Pfizer Corporation and Pfizer Products Inc., where his innovative spirit and dedication to scientific advancement have left an indelible mark.

Collaborations:

McHardy's success is also attributed to his collaborations with esteemed colleagues, including Jotham Wadsworth Coe and Spiros Liras. Together, they have worked tirelessly to push the boundaries of pharmaceutical research, developing pioneering solutions to address complex medical challenges.

Conclusion:

In conclusion, Stanton F. McHardy stands as a beacon of innovation in the field of pharmaceutical inventions. His relentless pursuit of scientific excellence has not only led to the creation of cutting-edge patents but has also brought hope to individuals seeking relief from cognitive impairments and various disorders. McHardy's legacy serves as a testament to the transformative power of innovation in improving the quality of life for countless individuals worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…